Test 7 Emulsions/ Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is the name of two things that totally mix

A

Solution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What two things are needed to make a solution

A

Solute and solvent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors that suggest that suspension is unstable

A

Aggregation
Sedimentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Substance distributed

A

Dispersed phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is another name for vehicle

A

Dispersing phase or dispersing medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What makes a dispersed system

A

Dispersed phase and dispersing medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List desirable properties of oral suspension

A

No grittiness
Uniform dispersion
Easy to pour but not watery
Particles should settle slowly
Readily redispersed when shook
Flocculated suspension
Palatable, good odour and colour
Insensitive to temp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Desirable suspeensions for injections

A

Synringeabiltiy
Sterile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Desirable characteristics for opthalmic susp

A

Smaller than 10um
Sterile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Desirable characteristics for topical

A

Fine particles avoid grittiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe sedimentation behaviour

A

Settling of particles/floccules due to gravity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ways of decreasing velocity

A

Smaller particle size
Increases viscosity and density of dispersion medium
Decrease density if dispersed phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do we ensure that a suspension is permanently well dispersed

A

Ask patient to shake bottle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Relationship between particle size wnd velocity

A

Directly proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Relationship between density dispersed and dispersion media wnd velocity

A

Directly proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Relationship between viscosity of dispersion medium wnd velocity

A

Inversely proportional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Define deflocculation

A

No flocs dominating repulsion forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define flocculations

A

Flocs formed attracting forces dominate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Repulsive forces are a result of

A

Electrostatic forces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the effect of neutral forces in APIs

A

More van der waals attraction that electrostatic = form flocs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the effect of charge in APIs

A

Electrstatic forces dominate=deflocs= cannot be easily redispersed due to repulsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How would you know the difference between a flocculated and deflocc solution by looking at it

A

Flocc top layer will be clear
Defloc top layer cloudy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In a deflocc solution why is the top of the solution cloudy

A

Due to repulsive forces, and stokes law, sedimentation of larger psrticles happens first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Explain flocculation

A

Weak bonds forming fluffy conglomerates
Settle rapidly but will jot form a cake
Easily resuspended
Clear supernatant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the speed of flocculated suspension

A

More rapid than deflocculated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What dies sedimentation depend on

A

Size and porosity if flocs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe energy in deflocculation

A

High repulsive energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Aggregation of particles in deflocculation

A

Caking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe supernatant in deflocculation

A

Turbid supernatant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Describe speed of sedimentation in deflocculation

A

Rate of sediment slow with larger particles sedimenting first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

In flocculated suspensions what particles settle first

A

All particles of size settle at same speed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

In terms of particles explain the difference between flocculated and deflocculated system

A

Defloc remain independent
Flocc particles link together to form loose structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

In terms of sedimentation state the difference between floc and defloc solution

A

Floc - all sediment at same speed in loose structure
Deflo- large sediment first but slowly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

In terms of supernatant describe different between flocculated and defloc system

A

Defloc- supernatant turbid for long time

Floc- supernatant quickly becomes clear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

In relation to dispersion, compare floc and defloc system

A

Defloc- may form hard cake irreversible

Floc- sediment remains loose and easy to redisperse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What does the sediment volume of ratio show

A

Qual knowledge physical stabiliy of suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Equation for sediment of volume ratio

A

Volume of sediment /total volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How can flocculation be controlled

A

Electrolytes- electrostatic stabilisation
Polymers - steric stabilisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

How are electrostatic electrolytes used in cotrolled flocculation

A

Electrolyte decrease the zeta potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How are polymers used in controlled flocculation

A

Work by absorption Hydrophilic polymers such as cellulose alginates acacia gelatin sodium oleate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Which forces lead to attractive interactions between two identically charge oarticles

A

VDW

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

A flocculated suspension is associated with

A

A large sediment volume and a clear supernatant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What property is a characteristic of deflocc suspension

A

Close packing of sediment to form a cake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What will enhance yhe stability of a drug suspension

A

Reducing particle size and increasing the viscosity of the suspension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

How are drugs approved

A

Benefits are deemed to outweigh their risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Are drugs safe

A

No all drugs have risks many are serious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Do OTC drugs have risks

A

Yes although fairly rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

How does the patient evaluate benefit and risks

A

Personal values

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

How does the HCP evaluate benefit and risks

A

Risks for the patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

How does the MHRA evaluate benefit and risks

A

Risks for population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What does the mhra stand for

A

Medicine and healthcare product regulatory agency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Describe the rofecoxib scandal

A

Approve for arthiritis but increased risk if heart attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Explain the effect of drug advertising on individuals

A

More exposure to meds which gives an impression of greater safety than actually exists
Take meds to maintain health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Definition of adverse drug reaction

A

Any harmful effect caused by admin of drug at NORMAL DOSAGE during NORMAL USE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Define risk/benefit ratio

A

Exposure to personal risk is recognise as a normal aspect of everyday life. We acceprs a certain level of risk in our lives as necessary to aschieve certain benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Frequency of ADR
Very common

A

10% or 1 in 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Frequency of ADR
Common

A

1% to 10%
1 in 10 to 1 in 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Frequency of ADR
Uncommon

A

0.1% to 1%
1 in 100 to 1 in 1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Frequency of ADR
Rare

A

0.01 to 0.1
1 in a 1000 to 1 in 10,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Frequency of ADR
Very rare

A

Less than 0.01% to less than 1 in 10,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What is pharmacovigilance also known as

A

Post marketing surveillance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Major goal of pharmacovigilance

A

Detect a signal on an unkowm serious adverse drug reaction ASAP
Obtain additional info unknown to marketing

63
Q

Effect of pharmacovigilance on labelling and pateint

A

Improve labelling of drug
Improve patient care and patient safety

64
Q

Limitations of clinical trials

A

Limited no of patients
Narrow population
Narrow indications
Short duration
No pregnancy
Concomitant meds controlled

65
Q

What action can be taken from pharmacovigilance findings

A

Restriction in use
Changes in dose of med
Introduce specific warning
Change legal status of med from otc to pom
Product recall

66
Q

International collabs for reporting meds

A

WHO
Eu union- EMA
Fda in us
Uk MHRA- yellow card scheme

67
Q

Where are yellow carss completed

A

Online and in the BNF

68
Q

What does rhe yellow card scheme act as

A

Early warning system for identification of unrecognised reactions

69
Q

What does the yellow card scheme collect information from

A

Side effects
Medical devices
Defective meds
Fake meds
Safety concerns from e cigs

70
Q

What ADRs should be reported

A

Death or serious illness
Minor risk with new medicine
Minor risk if associate with a child or in pregnancy

71
Q

What does black triangle mean on BNF

A

New Drug monitored closely for minimum of two years black triangle not removed until safety of drug is established

72
Q

ADR can result in the following:

A

Result in death
Life threatening
Requires hospitalisation
Disability
Congenital anomaly or birth defect
Medically significant

73
Q

Who can report ADRs

A

Patients /relatives
HCPs
Pharma companies
Authority

Any member of general public

74
Q

What does pharmacovigilance heavily rely in

A

Passive surveillance

75
Q

In terms of discipline what is pharmacovigilance

A

Dynamic clinical and scientific discipline

76
Q

How is a drug deemed successful

A

Promise invitro demonstrating a beneficial effect in animal and models as well as pass through 3 phases of human clinical trials

77
Q

Difference between invitro and in vivo

A

Invitro in cells
In vivo in life

78
Q

What is formulation

A

Putting compound in suitable vehicle

79
Q

How do you test stability

A

Different temperatures and humidity
Making sure that nothing happens to the drug

80
Q

What does phase 1 test

A

Safety in humans

81
Q

What does phase 2 test

A

Efficacy in patients

82
Q

What does phase 3 test

A

Safety and efficacy larger scale

83
Q

What does phase 0 test for

A

Effect on body

84
Q

What does phase 4 test for

A

Long term safety

85
Q

IMPD

A

Investigational medicinal product dossier
Certifies approval for clinical trials to take place

86
Q

MAA

A

Marketing authorisation application
Must be approves at the end of clinical trials

Equivalent to NDA

87
Q

EMA

A

European medicine agency
Revies the commercialised products

88
Q

Why are new drugs needed

A

Unmet medical need
Cost of therapy
Sustain industrial activity

89
Q

Explain the unmet medical need

A

New diseases

Low efficacy such as dementia and cancer

Side effects of antidepressants/ antipsychotics

90
Q

Purpose of drug patents

A

Protect ideas in pharmaceutical company

91
Q

Definition of formulation science

A

Transforming API into a quality drug product in a specific dosage form

92
Q

Purpose of formulation

A

For stability ease of administration or patient acceptability

93
Q

What does formulating a drug and excipients into a dosage form allow

A

Manipulation of dosing frequency

94
Q

How is choice of formulation important

A

When dealing with vulnerable populations eg children elderly

95
Q

What does preformulation study involve

A

Characterisation of api eg solubility/melting point
Investigation fo physicochemical properties alone and with excipients

96
Q

Choosing quant formula and process is also known as

A

Formulation development

97
Q

Transferring the process from lab to industrial is known as

A

Scale up and process validation

98
Q

Learning before doing is…

A

Pre-formulation studies

99
Q

What do drug discovery and preclinical trials involve

A

Preformulation
Formulation support for preclinical test
Developing a formulation for clinical trials

100
Q

What do clinical trials involve

A

Scaleup activities
Ontime supply of clinical trial material
Formulation development

101
Q

Post marketing surveillance can lead to..

A

Reformulation
2nd generation launch
Pom to otc

102
Q

Preformulation main areas of focus regarding physicochemical properties

A

Organoleptic properties- colour/odor/taste
Particles size and shapes-solubility
Purity-impurtities can be toxic
Surface area - solubility and dissolution

103
Q

Preformulation main areas of focus regarding
Bulk characteristics

A

Crystallinity and polymorphism- stability and compatibility
Bulk density- measure volume / weight
Powder flow properties
Hygroscopicity- how much water absorbed from air

104
Q

Preformulation main areas of focus regarding
Solubility studies

A

Aqueous solubility - must dissolve in git prior to absorption
Ph solubility
Log p- drug across membrane
Dissolution

105
Q

Preformulation main areas of focus regarding
Stability studies

A

Solid state- stable storage conditions snd investigate effect of pH:/ cosolvent/ temp/light
Solution
Bulk
Compatibility - look at interaction with other drugs

106
Q

What are drug candidates becoming

A

More lipophilic and poorly soluble

107
Q

What does the comprehensive report include

A

Problems associated with molecule

108
Q

Formulation studies involve

A

Delivery of robust and stable drug product formulations that consistently deliver the desired API:

109
Q

List the steps of formulation studies

A

Formulation design
Process development
Formulation support for preclinical test
Clinical trials
Scale up
Package development
Ongoing stability studies

110
Q

How did covid develop quickly

A

Funding
Urgency
Demand

111
Q

How did covid vaccine trigger immune system

A

Spike protein

112
Q

How did covid get approved quickly

A

Temp approval for specific batches of pfizer vaccine based on efficacy

Rolling revies process

113
Q

Why was covid vaccine temporary

A

Dont need eu approval
Approval for 1 year
Allow companies to continue studies and submit evidence

114
Q

Where can you find information for drug disposal

A

EMC
Patient leaflet

115
Q

What are preclinical trials

A

Non clinical studies is the stage of research that begins before testing in humans

116
Q

What is the purpose of pre clinical trials

A

Determine a products ultimate safety profile

117
Q

In preclinical trials, what is the main purpose

A

Test drugs and devices to see if theyre safe and effective

118
Q

What types of products are used in preclinical tests

A

New drugs
Medical devices
Gene therapy solutions

119
Q

What do individuals consider before taking medication

A

Effectiveness
Doee
How often
Side effects
Any interactions
Is it a cure

120
Q

Main aim of preclinical trials

A

Gather enough info to decide whether drug is safe to proceed with human trials

121
Q

Animals used in preclinical trials

A

Zebra fish
Mice and rodent models
Rabbits
Fruit fly

122
Q

List importance of preclinical trials

A

Determine dose, toxic dose , pharmacological action ,

Requirement if reg body

Consider ethical viewpoint

Kinetic profile

Effective route if admin

123
Q

In general animal studies are conducted in two species

A

Rodent
Non rodent

124
Q

How are safety pharmacology studies used in preclinical studies

A

Determine the effects of drug on specialised organ system

125
Q

How are carcinogenicity studies used in preclinical studies

A

Determine effects of long term exposure to drug including ability to produce cancer
Not used for short term use drugs

126
Q

How are reproductive toxicity studies used in preclinical studies

A

Evaluate effects on reproductive function & ability to produce birth defects

127
Q

List the 3 types of scientific models used

A

Insilico- computational modelling
Invitro in test tube
In living animals
In living humans

128
Q

Non animal and non humans models

A

In silico and in vitro

129
Q

Conditions of in vitro experimentation

A

Aseptic techniques
Biosafety cabinet
Cells grown at 37c and 5% co2

130
Q

Journey of in vitro experiment

A

Grow cells in flask
Then add to 96 well plate
Then plot IC50

131
Q

Pros and cons of in vitro models

A

Less expensive than in vivo
Faster than in vivo

Difficult to mimic complex physio environments

132
Q

What do screening models test in vitro models

A

Cytotoxicity
Protein binding
Cyp inhibition/induction
Membrane permeability

133
Q

What is a model organism

A

Non human species studies used to provide insight into working of other organisms

134
Q

Why are mouse models favoured

A

Close model to humans
High degree of genetic similarity

135
Q

Why are c elegans favoured

A

Grown and manipulated with speed and ease but includes key complex features of an organism

136
Q

Fruit fly

A

Easy to manipukaye
Used to study development, physio and behaviour
Well conserved genes -homologues

137
Q

Why are Zebra fish used as animal model

A

Small size short life cycle
Readily produce mutations relevant to human health and disease
Embryonic development

138
Q

Disadvantages of animal models

A

Lack of appropriate drug target in preclinical animal model
Irrelevant target
Difference in metabolism
Unethical

139
Q

Animal trials…

A

Are not always predictive

140
Q

Ethical considerations in animal studies

A

Refinement- minimise pain and suffering
Reduction- using a few animals as possible
Replacement- use other models

141
Q

Alternatives to animal models

A

In vitro or computational modelling by law if as effective as using animals
Use lowest animal eg fly rather than mouse

142
Q

Study details of preclinical trials

A

Only few out of thousands reach stage
Safety in at least two animal species
Oral and parenteral routes

143
Q

What are screening test

A

Simple and rapid test performed to indicate presence or absence of a particle pharmacodynamic activity

144
Q

What are tests on isolated organs, bacterial cultures

A

Preliminary tests to detect specific activity, eg antihistaminic/ antisecretory

145
Q

What are tests on animal models of human disease

A

Animals to study different type of drugs

146
Q

What is a general observational test

A

Drug injected in 3 doses to small group which are observed for hidden effects

147
Q

What are confirmatory tests and analogous activities

A

Test for active compounds

148
Q

What are mechanism of action studies

A

Attempt to find our mechanism of action

149
Q

What is systemic pharmacology

A

Effect of drug on major organ systems

150
Q

What are quantitave tests

A

Dose response relationship, maximal effects

151
Q

What are pharmacokinetic test

A

Absorprion, tissue distribution, metabolism, excretion

152
Q

IND

A

Investigational new drug
How drug is manufactured
Appears
Formulation intended
Analysis for purity/concentration and stability
Safety

153
Q

Common technical document

A

Set of spec containing all the quality safety and efficacy information
Used with other ICh and reg agency MHRA